What is measured?
Period-average diluted EPS denominator; not period-end shares outstanding.
Meta annual diluted weighted-average shares by fiscal year. Period-average diluted EPS shares, not shares outstanding on a single date.
5-year change · FY2020 to FY2025
Meta's diluted weighted-average shares were 2.574B in FY2025, down 314M (10.9%) from FY2020 and down 40M (1.5%) year over year.
The displayed period-change result was separately reviewed.
A company page opens when one exists. Other searches show current availability.
Each annual value opens the SEC filing that contains the displayed fact.
Source filing is the exact SEC document used for the displayed fact, not necessarily the filing that first reported that fiscal year. Later comparative filings are labeled below.
| Fiscal year | Diluted weighted-average shares | Change from previous displayed period | Filing containing fact | Source |
|---|---|---|---|---|
| FY20252025-12-31 | 2.574B | -1.5%FY2024 to FY2025 | 10-K2026-01-29 | |
| FY20242024-12-31 | 2.614B | -0.6%FY2023 to FY2024 | 10-K2026-01-29comparative period | |
| FY20232023-12-31 | 2.629B | -2.7%FY2022 to FY2023 | 10-K2026-01-29comparative period | |
| FY20222022-12-31 | 2.702B | -5.5%FY2021 to FY2022 | 10-K2025-01-30comparative period | |
| FY20212021-12-31 | 2.859B | -1.0%FY2020 to FY2021 | 10-K2024-02-02comparative period | |
| FY20202020-12-31 | 2.888B | +0.4%FY2019 to FY2020 | 10-K2023-02-02comparative period | |
| FY20192019-12-31 | 2.876B | -1.5%FY2018 to FY2019 | 10-K2022-02-03comparative period | |
| FY20182018-12-31 | 2.921B | -1.2%FY2017 to FY2018 | 10-K2021-01-28comparative period | |
| FY20172017-12-31 | 2.956B | +1.1%FY2016 to FY2017 | 10-K2020-01-30comparative period | |
| FY20162016-12-31 | 2.925B | +2.5%FY2015 to FY2016 | 10-K2019-01-31comparative period | |
| FY20152015-12-31 | 2.853B | +7.1%FY2014 to FY2015 | 10-K2018-02-01comparative period | |
| FY20142014-12-31 | 2.664B | n/a | 10-K2017-02-03comparative period |
Repurchase cash and SBC are SEC-reported USD measures shown for context. They are not netted and do not explain changes in diluted weighted-average shares.
Missing periods remain blank. Only source-backed observations are shown as zero.
| Adjustment | Basis | Accession | Source location | ||||||
|---|---|---|---|---|---|---|---|---|---|
| FY2014, period ended 2014-12-31 | 2014-12-31 | DWA shares | 2.7B | 2.7B | none | as reported | 10-K2017-02-03comparative period | 0001326801-17-000007 | Exact XBRL fact |
| FY2015, period ended 2015-12-31 | 2015-12-31 | DWA shares | 2.9B | 2.9B | none | as reported | 10-K2018-02-01comparative period | 0001326801-18-000009 | Exact XBRL fact |
| FY2016, period ended 2016-12-31 | 2016-12-31 | DWA shares | 2.9B | 2.9B | none | as reported | 10-K2019-01-31comparative period | 0001326801-19-000009 | Exact XBRL fact |
| FY2017, period ended 2017-12-31 | 2017-12-31 | DWA shares | 3.0B | 3.0B | none | as reported | 10-K2020-01-30comparative period | 0001326801-20-000013 | Exact XBRL fact |
| FY2018, period ended 2018-12-31 | 2018-12-31 | DWA shares | 2.9B | 2.9B | none | as reported | 10-K2021-01-28comparative period | 0001326801-21-000014 | Exact XBRL fact |
| FY2019, period ended 2019-12-31 | 2019-12-31 | DWA shares | 2.9B | 2.9B | none | as reported | 10-K2022-02-03comparative period | 0001326801-22-000018 | Exact XBRL fact |
| FY2020, period ended 2020-12-31 | 2020-12-31 | DWA shares | 2.9B | 2.9B | none | as reported | 10-K2023-02-02comparative period | 0001326801-23-000013 | Exact XBRL fact |
| FY2021, period ended 2021-12-31 | 2021-12-31 | DWA shares | 2.9B | 2.9B | none | as reported | 10-K2024-02-02comparative period | 0001326801-24-000012 | Exact XBRL fact |
| FY2022, period ended 2022-12-31 | 2022-12-31 | DWA shares | 2.7B | 2.7B | none | as reported | 10-K2025-01-30comparative period | 0001326801-25-000017 | Exact XBRL fact |
| FY2023, period ended 2023-12-31 | 2023-12-31 | DWA shares | 2.6B | 2.6B | none | as reported | 10-K2026-01-29comparative period | 0001628280-26-003942 | Exact XBRL fact |
| FY2024, period ended 2024-12-31 | 2024-12-31 | DWA shares | 2.6B | 2.6B | none | as reported | 10-K2026-01-29comparative period | 0001628280-26-003942 | Exact XBRL fact |
| FY2025, period ended 2025-12-31 | 2025-12-31 | DWA shares | 2.6B | 2.6B | none | as reported | 10-K (FY2025)2026-01-29 | 0001628280-26-003942 | Exact XBRL fact |
Each row connects a displayed value to an SEC filing and taxonomy tag. Open Technical details for the XBRL context, unit, decimals, and dimensions available for that row.
| Period | Metric | Chart value | Filing | Accession | Taxonomy tag | Source location | Source |
|---|---|---|---|---|---|---|---|
| value | links | ||||||
| FY2014, period ended 2014-12-312014-12-31 | DWA shares | 2.7B | 10-K2017-02-03comparative period | 0001326801-17-000007 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView XBRL sourceCompany Facts |
| FY2015, period ended 2015-12-312015-12-31 | DWA shares | 2.9B | 10-K2018-02-01comparative period | 0001326801-18-000009 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView XBRL sourceCompany Facts |
| FY2016, period ended 2016-12-312016-12-31 | DWA shares | 2.9B | 10-K2019-01-31comparative period | 0001326801-19-000009 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView XBRL sourceCompany Facts |
| FY2017, period ended 2017-12-312017-12-31 | DWA shares | 3.0B | 10-K2020-01-30comparative period | 0001326801-20-000013 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2018, period ended 2018-12-312018-12-31 | DWA shares | 2.9B | 10-K2021-01-28comparative period | 0001326801-21-000014 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2019, period ended 2019-12-312019-12-31 | DWA shares | 2.9B | 10-K2022-02-03comparative period | 0001326801-22-000018 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2020, period ended 2020-12-312020-12-31 | DWA shares | 2.9B | 10-K2023-02-02comparative period | 0001326801-23-000013 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2021, period ended 2021-12-312021-12-31 | DWA shares | 2.9B | 10-K2024-02-02comparative period | 0001326801-24-000012 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2022, period ended 2022-12-312022-12-31 | DWA shares | 2.7B | 10-K2025-01-30comparative period | 0001326801-25-000017 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2023, period ended 2023-12-312023-12-31 | DWA shares | 2.6B | 10-K2026-01-29comparative period | 0001628280-26-003942 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2024, period ended 2024-12-312024-12-31 | DWA shares | 2.6B | 10-K2026-01-29comparative period | 0001628280-26-003942 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2025, period ended 2025-12-312025-12-31 | DWA shares | 2.6B | 10-K (FY2025)2026-01-29 | 0001628280-26-003942 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
Period-average diluted EPS denominator; not period-end shares outstanding.
Changes compare matching fiscal-year observations. A window is unavailable unless its exact start and end fiscal years are present in the checked series.
Repurchase cash and stock-based compensation are contextual USD measures. They are not components of the share-count calculation and do not establish causation.
The displayed period-change result was separately reviewed.
Use the source trace and displayed data table to inspect filing, accession, period, unit, and XBRL trace.
Not investment advice. This page describes what filings report about share counts — research and education only, not investment, trading, tax, legal, or personalized financial advice.